Form 4: Aerovate Therapeutics' Chief Medical Officer, Hunter Gillies, Executes Stock Options and Sells Shares
SEC Form 4
Hunter Gillies, Chief Medical Officer of Aerovate Therapeutics, exercised stock options and sold shares on March 18, 2024, according to a Form 4 filing with the SEC.
Summary
- On March 18, 2024, Hunter Gillies, the Chief Medical Officer of Aerovate Therapeutics, exercised stock options to acquire 4,000 shares at $1.74 and 3,000 shares at $2.14.
- Following the exercise of these options, Gillies sold 6,387 shares at a weighted average price of $25.8137 and 613 shares at a weighted average price of $26.4022.
- After these transactions, Gillies directly owns 3,251 shares of Aerovate Therapeutics common stock.
- Gillies also holds options to purchase 4,036 shares at $1.74 and 98,510 shares at $2.14.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, as it's simply a record of stock option exercises and share sales.
Industry Context
This filing is a routine disclosure of insider transactions. It's common for executives to exercise stock options and sell shares, especially under pre-arranged trading plans like Rule 10b5-1, which allows insiders to trade without being accused of acting on non-public information.
Key Dates
| Date | Description |
|---|---|
| January 19, 2023 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| March 18, 2024 | Date of the reported transactions (exercise of stock options and sale of shares) |
| March 20, 2024 | Date of the signature on the Form 4 filing |
| September 03, 2030 | Expiration date of stock options granted on September 4, 2020 |
| April 01, 2031 | Expiration date of stock options granted on April 2, 2021 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.